🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Neurocrine Biosciences, Inc. (NBIX)
NASDAQ: NBIX · Real-Time Price · USD
154.68
-1.91 (-1.22%)
Nov 20, 2026, 10:20 AM EST - Market open

Neurocrine Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
641.5713233251.1262.9340.8
Short-Term Investments
96.4767.4843.1780.5726.4370.5
Cash & Short-Term Investments
737.91,4801,0761,032989.3711.3
Cash Growth
-33.81%37.57%4.31%4.28%39.08%-11.20%
Receivables
959686.8479.1439.3350185.5
Inventory
66.16957.438.335.130.5
Prepaid Expenses
212.4170.748.5---
Other Current Assets
32.8115.863.697.879.145.5
Total Current Assets
2,0082,5231,7251,6071,454972.8
Property, Plant & Equipment
529.4545.2592347.3145.6155.8
Long-Term Investments
146.81,184864.3849.4401.5624.4
Goodwill
500.6--5.85.4-
Other Intangible Assets
2,191--35.537.2-
Long-Term Deferred Tax Assets
11.8320.3485.7362.6305.9315.1
Other Long-Term Assets
233.559.55243.819.64.4
Total Assets
5,6274,6323,7193,2512,3692,073

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
150.5104.999.9133.367.351.5
Accrued Expenses
622.8501.4351.7315.5271.3111.6
Current Portion of Long-Term Debt
---170.1169.4-
Current Portion of Leases
59.556----
Current Income Taxes Payable
150.16810-9-
Current Unearned Revenue
-----62.7
Other Current Liabilities
1.713.146.135.920.720
Total Current Liabilities
984.6743.4507.7654.8537.7245.8
Long-Term Debt
-----335.1
Long-Term Leases
392.3415.3455.1258.393.5105.3
Other Long-Term Liabilities
266.8219.7166.2106.329.712.3
Total Liabilities
1,7491,3781,1291,019660.9698.5

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.10.10.10.10.10.1
Additional Paid-In Capital
3,0362,7922,5552,3822,1222,011
Retained Earnings
838.4447.729.2-157.1-406.8-635.8
Comprehensive Income & Other
4.413.15.87-7.9-1.7
Shareholders' Equity
3,8793,2532,5902,2321,7081,374
Total Liabilities & Equity
5,6274,6323,7193,2512,3692,073

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
451.8471.3455.1428.4262.9440.4
Net Cash (Debt)
286.11,009621603.2726.4270.9
Net Cash Growth
-54.95%62.50%2.95%-16.96%168.14%-30.31%
Net Cash Per Share
2.759.845.995.977.342.77
Filing Date Shares Outstanding
101.22100.3699.799.5196.5995.24
Total Common Shares Outstanding
101.3100.199.498.796.594.9
Working Capital
1,0241,7791,217952.2915.8727
Book Value Per Share
38.2932.5026.0522.6117.7014.48
Tangible Book Value
1,1873,2532,5902,1911,6651,374
Tangible Book Value Per Share
11.7232.5026.0522.2017.2614.48
Machinery
-172.5153.2115.78775.6
Leasehold Improvements
-35.635.938.137.934.9
SEC Filings: 10-K · 10-Q